KI RISTIA ALLEN-LAMPE: Open Payments
NPI 1255754529 · SWANSEA, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$459 in 20 payments from 9 companies in 2025. Trend: 2023 $405 · 2024 $458 · 2025 $459
Food & beverage: $459
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 1 | $92 |
| AstraZeneca Pharmaceuticals LP | 4 | $80 |
| Novo Nordisk Inc | 4 | $72 |
| ABBVIE INC. | 3 | $61 |
| Supernus Pharmaceuticals, Inc. | 2 | $44 |
| Lilly USA, LLC | 2 | $35 |
| Lundbeck LLC | 2 | $35 |
| Janssen Pharmaceuticals, Inc | 1 | $20 |
| Otsuka America Pharmaceutical, Inc. | 1 | $19 |
Products named: AUSTEDO XR, BREZTRI, Wegovy, REXULTI, VRAYLAR, Qelbree, ZEPBOUND, AIRSUPRA.
Industry payments across IL — which companies pay providers there.
